GLP-1 drugs increase healthcare costs for obese patients

Original Article by Chad Terhune | Reuters | 25 October 2024

Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.

Healthcare costs for US obesity patients rise with GLP-1 drugs despite their weight-loss benefits.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here